Lataa...
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.
Prophylactic treatment with fluoroquinolones of patients with profound neutropenia has been found to be useful for preventing gram-negative bacteremia and has become a standard preventive-therapy strategy in many cancer centers, but the development of bacterial resistance is a cause of concern. Duri...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1994
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284525/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8031031/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.4.681 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|